Abstract
Ventricular remodelling is the basis of differences in cardiac structure as hypertrophy due to pressure overload or ventricular dilation leading to heart failure. The heart structure is essentially influenced by the extracellular matrix (ECM). Only in this scaffold cardiac myocytes and vascular cells can do their function and a normal myocardial contractility is possible. The structure of the cardiac extracellular matrix depends on cardiac fibroblast collagen synthesis, on the activity of fibrillar collagen degrading proteolytic enzymes and their endogenous tissue inhibitors. The main component of the ECM are the fibrillar collagens. Collagen type I and type III are the major types present in myocardium in both normal and diseased myocardial tissue. Other collagens like type IV and type VII are important for basement membrane stability. Collagen biosynthesis is regulated at different levels of transcription and translation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, J.W., Sakata, Y., Davis, M.G., Sah, V.P., Wang, Y., Liggett, S.B., Chien, K.R., Brown, J.H., Dorn, G.W. 2nd., 1998, Enhanced Gaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. U.S.A. 95: 10140–10145.
Baudin, B., 2002, Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics. 3: 65–73.
Blobe, G.C., Schiemann, W.P., Lodish, H.F., 2000, Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342: 1350–1358.
Böhm, M., Flesch, M., Schnabel, P., 1997, Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J. Mol. Med. 75: 842–848.
Border, W.A., Noble, N.A., 1994, Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286–1292.
Brenner, D.A., Rippe, R.A., Rhodes, K., Trotter, J.F., Breindl, M, 1994, Fibrogenesis and type I collagen gene regulation. J. Lab. Clin. Med. 124: 755–760.
Brilla, C.G., Zhou, G., Matsubara, L., Weber, K.T., 1994, Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol. 26: 809–820.
Butt, R.P., Laurent, G.J., Bishop, J.E., 1995, Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur. J. Cell Biol. 68: 330–335.
Catellano, M., Böhm, M., 1997, The cardiac β-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 29: 715–722.
Coker, M.L., Jolly, J.R., Joffs, C., Etoh, T., Holder, J.R., Bond, B.R., Spinale, F.G., 2001, Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am. J. Physiol. Heart. Circ. Physiol. 281: H543–551.
Dostal, D.E., 2001, Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors. Hypertension. 37: 841–844.
Edwards, D.R., Murphy, G., Reynolds, J.J., Whitham, S.E., Docherty, A.J., Angel, P., Heath, J.K., 1987,Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6: 1899–1904.
Everett, A.D., Tufro-McReddie, A., Fisher, A., Gomez, R.A., 1994, Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension. 23: 587–592.
Fujisaki, H., Ito, H., Hirata, Y., Tanaka, M., Hata, M., Lin, M., Adachi, S., Akimoto, H., Marumo, F., Hiroe, M., 1995, Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J. Clin. Invest. 96: 1059–1065.
Gonzalez, A., Lopez, B., and Diez, J., 2002, Myocardial fibrosis in arterial hypertension. Eur. Heart J. Suppl. 4: D18–D22.
Guarda, E., Katwa, L.C., Myers, P.R., Tyagi, S.C., Weber, K.T., 1993, Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27: 2130–2134.
Gudi, S.R., Lee, A.A., Clark, C.B., Frangos, J.A., 1998, Equibiaxial strain and strain rate stimulate early activation of G proteins in cardiac fibroblasts. Am. J. Physiol. 274: C1424–1428.
Katwa, L.C., Guarda, E., Weber, K.T., 1993, Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc. Res. 27: 2125–2129.
Kouchi, I., Zolk, O., Jockenhövel, F., Itter, G., Linz, W., Cremers, B., Böhm, M., 2000, Increase in Giα-protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathy. Hypertension. 36: 42–47.
Lopez, B., Querejeta, R., Varo, N., Gonzalez, A., Larman, M., Martinez Ubago, J.L., Diez, J., 2001, Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 104: 286–291.
Matsusaka, T., Katori, H., Inagami, T., Fogo, A., Ichikawa, I., 1999, Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. J. Clin. Invest. 103: 1451–1458.
Montfort, I. and Perez-Tamayo, R., 1975, The distribution of collagenase in normal rat tissues. J. Histochem. Cytochem. 23: 910–920.
Mujumdar, V.S., Smiley, L.M., Tyagi, S.C., 2001, Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int. J. Cardiol. 79: 277–286.
Nagatomo, Y., Carabello, B.A., Coker, ML., McDermott, P.J., Nemoto, S., Hamawaki, M., Spinale, F.G., 2000, Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am. J. Physiol. Heart. Circ. Physiol. 278: H151–161.
Olivetti, G., Melissari, M., Balbi, T., Quaini, F., Cigola, E., Sonnenblick, E.H., Anversa, P., 1994, Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc. Res. 28: 1199–1208.
Pathak, M., Sarkar, S., Vellaichamy, E., Sen, S., 2001, Role of myocytes in myocardial collagen production. Hypertension. 37: 833–840.
Pearlman, E.S., Weber, K.T., Janicki, J.S., Pietra, G.G., Fishman, A.P., 1982, Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab. Invest. 46: 158–164.
Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A.B., Sporn, M.B., Thorgeirsson, S.S., 1995, Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. U.S.A. 92: 2572–2576.
Schunkert, H., Orzechowski, H.D., Bocker, W., Meier, R., Riegger, G.A., Paul, M., 1999, The cardiac endothelin system in established pressure overload left ventricular hypertrophy. J. Mol. Med. 77: 623–630.
Seeland, U., Kouchi, I., Zolk, O., Itter, G., Linz, W., Böhm, M., 2002a, Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J. Mol. Cell. Cardiol. 34: 151–163.
Seeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter-Kochanek, K., Böhm, M., 2002b, Myocardial fibrosis in transforming growth factor-beta(l) (TGF-beta(l)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest. 32: 295–303.
Spinale, F.G., 2002, Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases. Circ. Res. 91: 1082–1084.
Tsuruda, T., Boerrigter, G., Huntley, B.K., Noser, J.A., Cataliotti, A., Costello-Boerrigter, L.C., Chen, H.H., Burnett, J.C. Jr., 2002, Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ. Res. 91: 1127–1134.
Villarreal, F.J. and Dillmann, W.H., 1992, Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin and collagen. Am. J. Physiol. 262: H1861–H1866.
Weber, K.T. and Brilla, C.G., 1991, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation. 83: 1849–1865.
Weber, K.T., Brilla, C.G., Campbell, S.E., 1992, Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies. Cardiology. 81: 266–273.
Yamamoto, K., Masuyama, T., Sakata, Y., Mano, T., Nishikawa, N., Kondo, H., Akehi, N., Kuzuya, T., Miwa, T., Hori, M., 2000, Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts. Cardiovasc. Res. 47: 274–283.
Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., Böhm, M., 1999, Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation. 99: 2118–2123.
Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., Böhm, M., 2002, Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Cardiovasc. Res. 53: 363–371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Seeland, U., Böhm, M. (2003). Cardiac Remodelling in Pressure Overload Hypertrophy. In: Lendeckel, U., Hooper, N.M. (eds) Proteases in Tissue Remodelling of Lung and Heart. Proteases in Biology and Disease, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9082-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9082-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4786-6
Online ISBN: 978-1-4419-9082-2
eBook Packages: Springer Book Archive